Literature DB >> 7237303

Steroid receptors in adjuvant hormonal therapy for breast cancer.

J H Goldie, N Bruchovsky, A J Coldman, G A Gudauskas.   

Abstract

Using a computerized mathematical model the authors found that either a small [5%] or large [50%] hormone-dependent reduction in tumour cell population at the beginning of adjuvant chemotherapy for breast cancer greatly increases the probability fo achieving a cure. The fact that even a minor response to hormonal therapy early in the treatment of the tumor is effective underlines the importance of using estrogen receptors to to select potential responders in whom a cure is at least a strong theoretical possibility.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7237303

Source DB:  PubMed          Journal:  Can J Surg        ISSN: 0008-428X            Impact factor:   2.089


  5 in total

1.  Adjuvant chemotherapy for early breast cancer.

Authors:  L A Price; B T Hill
Journal:  Br Med J (Clin Res Ed)       Date:  1983-09-24

2.  Anti-estrogen treatment of postmenopausal breast cancer patients with high risk of recurrence: 72 months of life-table analysis and steroid hormone receptor status.

Authors:  C Rose; H T Mouridsen; S M Thorpe; J Andersen; M Blichert-Toft; K W Andersen
Journal:  World J Surg       Date:  1985-10       Impact factor: 3.352

3.  Antiestrogen treatment of postmenopausal women with primary high risk breast cancer.

Authors:  C Rose; S M Thorpe; H T Mouridsen; J A Andersen; H Brincker; K W Andersen
Journal:  Breast Cancer Res Treat       Date:  1983       Impact factor: 4.872

Review 4.  Drug resistance and cancer chemotherapy strategy in breast cancer.

Authors:  J H Goldie
Journal:  Breast Cancer Res Treat       Date:  1983       Impact factor: 4.872

5.  Long-term tamoxifen adjuvant therapy in node-positive breast cancer: a metabolic and pilot clinical study.

Authors:  D C Tormey; V C Jordan
Journal:  Breast Cancer Res Treat       Date:  1984       Impact factor: 4.872

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.